GC
CNMD icon

Guggenheim Capital’s CONMED CNMD Stock Holding History

Guggenheim Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,009
Closed -$225K – 1871
2019
Q4 		$225K Sell
2,009
-1,728
-46% -$184K ﹤0.01% 1941
2019
Q3 		$359K Sell
3,737
-1,026
-22% -$96.3K ﹤0.01% 1773
2019
Q2 		$408K Sell
4,763
-8,712
-65% -$716K ﹤0.01% 1745
2019
Q1 		$1.12M Sell
13,475
-7,219
-35% -$525K 0.01% 1325
2018
Q4 		$1.33M Buy
+20,694
New +$1.42M 0.01% 1248
2016
Q4 		– Sell
-20,403
Closed -$817K – 2915
2016
Q3 		$817K Sell
20,403
-2,310
-10% -$98.1K ﹤0.01% 2183
2016
Q2 		$1.08M Sell
22,713
-884
-4% -$37.4K ﹤0.01% 2003
2016
Q1 		$990K Buy
+23,597
New +$926K ﹤0.01% 2063

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Guggenheim Capital's CNMD Position: Q1 2020 in Review

Guggenheim Capital sold out of CONMED (CNMD) in Q1 2020, closing a stake of 2,009 shares — an estimated $225K sold.

Guggenheim Capital first reported a position in CNMD in Q1 2016 and held it in 8 quarters. The position peaked at $1.33M in Q4 2018. 228 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • Guggenheim Capital reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
  • Guggenheim Capital sold 2,009 CONMED shares in Q1 2020, an estimated $225K.
  • Guggenheim Capital first reported a position in CONMED in Q1 2016 and held it in 8 quarters.
  • Guggenheim Capital's CONMED position peaked at $1.33M in Q4 2018.
  • 228 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on Guggenheim Capital's 13F filing for Q1 2020, filed 2 Jun 2020.